Advances in Cervical Cancer

Olivia W Foley¹, Danielle Strom², Emily M Hinchcliff³

Affiliations

¹ Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Prentice Women's Hospital, 250 E Superior Street Floor 5, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Prentice Women's Hospital, 250 E Superior Street Floor 4, Chicago, IL 60611, USA.
² Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Prentice Women's Hospital, 250 E Superior Street Floor 5, Chicago, IL 60611, USA.
³ Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Prentice Women's Hospital, 250 E Superior Street Floor 5, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Prentice Women's Hospital, 250 E Superior Street Floor 4, Chicago, IL 60611, USA. Electronic address: emily.hinchcliff@nm.org.

PMID: 41173595
DOI: 10.1016/j.hoc.2025.04.016

Review

Advances in Cervical Cancer

Olivia W Foley et al. Hematol Oncol Clin North Am. 2025 Dec.

. 2025 Dec;39(6):1121-1137.

doi: 10.1016/j.hoc.2025.04.016.

Authors

Olivia W Foley¹, Danielle Strom², Emily M Hinchcliff³

Affiliations

¹ Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Prentice Women's Hospital, 250 E Superior Street Floor 5, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Prentice Women's Hospital, 250 E Superior Street Floor 4, Chicago, IL 60611, USA.
² Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Prentice Women's Hospital, 250 E Superior Street Floor 5, Chicago, IL 60611, USA.
³ Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Prentice Women's Hospital, 250 E Superior Street Floor 5, Chicago, IL 60611, USA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Prentice Women's Hospital, 250 E Superior Street Floor 4, Chicago, IL 60611, USA. Electronic address: emily.hinchcliff@nm.org.

PMID: 41173595
DOI: 10.1016/j.hoc.2025.04.016

Abstract

Cervical cancer continues to represent an immense burden worldwide. Fortunately, in all stages of the disease and therapeutic modalities there have been significant advances in the past 5 years with the promise of improving oncologic outcomes and decreasing morbidity. The introduction of immunotherapy into the care of patients with metastatic and recurrent cervical cancer, a disease with a historically poor prognosis and limited treatment options, has altered the standard of care.

Keywords: Adjuvant chemotherapy; Cancer staging; Cervical cancer; Chemoradiation; Immunotherapy; Surgical approach.

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Advances in Cervical Cancer

Affiliations

Advances in Cervical Cancer

Authors

Affiliations

Abstract

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous